miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1

por Tan, Wenliang, Lin, Zhirong, Chen, Xianqing, Li, Wenxin, Zhu, Sicong, Wei, Yingcheng, Huo, Liyun, Chen, Yajin, Shang, Changzhen
Publicado 2021

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

por Tan, Wenliang, Zhang, Kelin, Chen, Xinming, Yang, Lei, Zhu, Sicong, Wei, Yingcheng, Xie, Zhiqin, Chen, Yajin, Shang, Changzhen
Publicado 2022

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway

por Yang, Lei, Tan, Wenliang, Wei, Yingcheng, Xie, Zhiqin, Li, Wenxin, Ma, Xiaowu, Wang, Qingbin, Li, Huilong, Zhang, Ziyu, Shang, Changzhen, Chen, Yajin
Publicado 2022